← Evidence map

ReviewTherapeutic advances in medical oncology2025

Predictive value of biomarkers for lenvatinib in hepatocellular carcinoma.

Xiangyong Hao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 40851753